Forbes October 10, 2024
Naveen Rao

Morgan Stanley’s latest report pegs the BCI market at $400 billion in the US alone.

“Brain Computer Interface Primer: The Next Big MedTech Opportunity?” by the bank’s equity analysts provides timely research, signaling to investors that this emerging frontier holds potential to generate substantial returns in future decades.

Note: As of publishing this article, Morgan Stanley’s 37-page report appears unlinked to a dedicated url, but the PDF has been circulating the commercial corridors of neurotech networks. This article is not the report. I’ll update this article with a dedicated link if I find one; If you are unable to access the file, just reach out.

Major Takeaways

In addition to a brief summary of BCI’s origins and commercial history, the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Survey / Study, Trends
Phillips launches updated AI tech for MRI scanners
Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces
Building Solid Relationships with Universities Critical for Early Stage Medtech Investors
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions
Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment

Share This Article